And we proposed that dexmedetomidine can inhibit the inflammatory response to protect the material transfer function of neurons axon and reduce the metabolic disorders of Aβ42 protein and Tau protein, even Aβ42 converted from APP (amyloid precursor protein) by β-secretase. Here, MAPT is linked to Other metabolic disease.